Blue plastic basket filled with Ozempic dispensers. Photo by Chemist4U CC 2.0

GLP‑1 drugs may fight addiction across every major substance, according to a study of 600,000 people

In the group already struggling with addiction, there were 50% fewer deaths due to substance use among those taking GLP-1 drugs compared with those who were not. We also found 39% fewer overdoses, 26% fewer drug-related hospitalizations and 25% fewer suicide attempts. Over three years, this translated to roughly 12 fewer serious events in total per 1,000 people using GLP-1 drugs – including two fewer deaths.

Continue reading
ChatGPT of a multicolored spiral.

Can a psychedelic-induced mystical experience really improve your mental health?

Mystics once spent years meditating in caves in search of transcendence. Today, a growing number of people believe something similar can be reached in a single afternoon with the help of a psychedelic drug. Swallow a capsule of psilocybin or take a carefully supervised dose of LSD and you may encounter what many describe as one of the most meaningful experiences of their lives. Modern clinical trials appear to support this.

Continue reading
BPC 157.svg

How a Croatian Lab Spawned a Buzzy Peptide Now Popular With MAHA

BPC-157 is a kind of chemical called a peptide, and the U.S. Food and Drug Administration treats it and some other peptides as unapproved drugs — going so far in 2023 as to explicitly prohibit compounding pharmacies from supplying BPC-157 to patients. Health and Human Services Secretary Robert F. Kennedy Jr. has more recently signaled a desire to loosen restrictions on experimental medical treatments, including unapproved peptides like BPC-157.

Continue reading
Photo of an infant with a measles rash.

RFK Jr. guts the US childhood vaccine schedule despite its decades-long safety record

Major medical organizations, including the American Academy of Pediatrics and the American College of Obstetricians and Gynecologists, have said that they will continue recommending the full complement of childhood vaccines. Several states, including California, New York, Illinois and Washington state, will follow established guidelines rather than the new federal recommendations, creating a patchwork where children’s protection depends on where they live.

Continue reading